What Does The Historic and Future Market Size Suggest For The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market?
The anti-vascular endothelial growth factor therapeutics market size has experienced marginal growth in recent years, increasing from $12.2 billion in 2024 to $12.31 billion in 2025 at a compound annual growth rate (CAGR) of 1.0%. This growth can be attributed to factors such as the rise in age-related macular degeneration, increased incidence of diabetic retinopathy, advancements in retinal disease diagnosis, clinical success and efficacy, and a shift towards outpatient treatment.
The market is expected to see steady growth in the coming years, reaching “$13.49 billion in 2029 at a compound annual growth rate (CAGR) of 2.3%. This growth is primarily driven by factors such as an aging population with ocular diseases, expanding applications in retinal disorders, development of next-generation therapeutics, increasing emphasis on early intervention, and improved access to treatment. Major trends contributing to this forecasted growth include increasing utilization in cancer treatment, the focus on combination therapies in ophthalmology, the exploration of biosimilar versions, research on resistance mechanisms, and integration with imaging technologies.
To view a free sample of The Global Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025, visit https://www.thebusinessresearchcompany.com/sample.aspx?id=10683&type=smp
What Are The Key Drivers Of The Anti-Vascular Endothelial Growth Factor Therapeutics Market Growth?
An increase in the prevalence of ophthalmic diseases is expected to propel the growth of the anti-vascular endothelial growth factor therapeutics market in the future. The global burden of ophthalmic diseases is considerable, with approximately 2.2 billion people having near or distance vision impairment, and 1 billion suffering from near or distance vision impairment as noted by World Health Organization in October 2022. Moreover, specific eye conditions such as refractive errors, cataracts, age-related macular degeneration, and diabetic retinopathy affect millions of individuals worldwide. Anti-vascular endothelial growth factor (VEGF) therapeutics play a fundamental role in mitigating these conditions, thereby driving market growth.
What Are The Key Segments Within The Anti-Vascular Endothelial Growth Factor Therapeutics Market?
The report segments the anti-vascular endothelial growth factor therapeutics market as follows:
1) By Product: Eylea, Lucentis, Beovu
2) By Disease: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration
3) By End Users: Hospitals, Clinics, Oncology Centers, Other End Users
To get a complete understanding of the market dynamics, order your report now at
https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report
Who Are The Main Players In The Anti-Vascular Endothelial Growth Factor Therapeutics Market?
Major companies operating in the anti-vascular endothelial growth factor therapeutics market include F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., Coherus BioSciences Inc., Eli Lilly and Company, Bausch Health Companies Inc., Viatris Inc., Xbrane Biopharma AB, Bayer AG, Regeneron Pharmaceuticals Inc., Genentech Inc, Allergan Inc., Novartis AG, kyowa Kirin Co. Ltd., Amgen Inc., AstraZeneca plc, Merck & Co. Inc., Johnson & Johnson Private Limited, Sanofi S.A., AbbVie Inc., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, and Alexion Pharmaceuticals Inc.
What Are The Emerging Trends In The Anti-Vascular Endothelial Growth Factor Therapeutics Market?
Advancements in therapeutics are a key trend gaining traction in the anti-vascular endothelial growth factor therapeutics market. Companies operating in this space are incorporating advanced therapeutics to maintain their market position. One illustration of this is Ashvattha Therapeutics Inc., which in May 2022, released phase 1 safety data for healthy subjects for subcutaneous anti-VEGF wet AMD and DME candidates.
What Does The Regional Analysis Suggest For The Anti-Vascular Endothelial Growth Factor Therapeutics Market?
In 2024, North America was the largest region in the anti-vascular endothelial growth factor therapeutics market. During the forecast period, Europe is expected to be the fastest-growing region. Other regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025 Offer?
Anti-Vascular Endothelial Growth Factor (VEGF) therapeutics are drugs used predominantly in the treatment of ophthalmic diseases by inhibiting the growth of blood vessels. The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. To purchase the report, visit https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10683
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model